Miruzzi L et al., 2026-01-22: Case report of a woman in her 70s whose hypoxia was assumed acquired but proved to be type 1 congenital methemoglobinemia on genetic testing.
Although she was taking cetirizine and indapamide, both of which have theoretical potential to induce acquired methaemoglobinaemia, genetic testing identified a homozygous pathogenic variant in cytochrome b5 reductase, confirming type 1 methaemoglobinaemia.
Miruzzi L et al., 2026-01-22: Case report of a woman in her 70s whose hypoxia was assumed acquired but proved to be type 1 congenital methemoglobinemia on genetic testing. C4. Study type: single case report (BMJ Case Reports 2026), N=1, woman in her 70s with COPD, Mater Dei Hospital, Msida, Malta. MetHb 26.5% found on blood gas after persistent hypoxia (SpO2 86%). Homozygous pathogenic cytochrome b5 reductase variant. Documents that congenital type 1 can present or be discovered in old age and be mistaken for a drug effect. Treatment sentence not captured in the abstract; funder/conflicts not stated in the PubMed record. Study type: case report.
